Sandra Milligan
President bij ASPIRA WOMEN'S HEALTH INC.
Vermogen: 575 421 $ op 31-03-2024
Profiel
Mevrouw Sandra Milligan is Onafhankelijk Bestuurder bij Gossamer Bio, Inc. en Hoofd Onderzoek & Ontwikkeling bij Organon & Co. Zij zit in de Raad van Bestuur van Gossamer Bio, Inc. Mevrouw Milligan was voorheen werkzaam als Vice President-Regulatory Affairs bij Genentech, Inc. Zij behaalde haar doctoraal aan de Universiteit van Californië, Irvine, een graduaat aan het Georgetown University Law Center en een doctoraat aan de George Washington University School of Medicine & Health.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ORGANON & CO.
0.01% | 04-05-2023 | 28 599 ( 0.01% ) | 537 661 $ | 31-03-2024 |
GOSSAMER BIO, INC.
0.01% | 15-11-2023 | 32 000 ( 0.01% ) | 37 760 $ | 31-03-2024 |
Actieve functies van Sandra Milligan
| Bedrijven | Functie | Begin |
|---|---|---|
| GOSSAMER BIO, INC. | Director/Board Member | 10-06-2021 |
| ASPIRA WOMEN'S HEALTH INC. | President | 01-04-2024 |
Eerdere bekende functies van Sandra Milligan
| Bedrijven | Functie | Einde |
|---|---|---|
| ORGANON & CO. | Chief Tech/Sci/R&D Officer | 01-01-2024 |
| MERCK & CO., INC. | Chief Tech/Sci/R&D Officer | 01-04-2020 |
Drug Information Association
 Drug Information Association Miscellaneous Commercial ServicesCommercial Services The Drug Information Association is a non-profit multidisciplinary association that operates to promote health and well-being. The non-profit company is based in Horsham, PA. Marwan Fathallah has been the CEO of the company since 2023. | Director/Board Member | 01-01-2017 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01-01-2015 |
| AMGEN INC. | Corporate Officer/Principal | 01-01-2012 |
Opleiding van Sandra Milligan
| University of California, Irvine | Undergraduate Degree |
| Georgetown University Law Center | Graduate Degree |
| George Washington University School of Medicine & Health | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 5 |
|---|---|
| AMGEN INC. | Health Technology |
| MERCK & CO., INC. | Health Technology |
| ASPIRA WOMEN'S HEALTH INC. | Health Technology |
| GOSSAMER BIO, INC. | Health Technology |
| ORGANON & CO. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Drug Information Association
Drug Information Association Miscellaneous Commercial ServicesCommercial Services The Drug Information Association is a non-profit multidisciplinary association that operates to promote health and well-being. The non-profit company is based in Horsham, PA. Marwan Fathallah has been the CEO of the company since 2023. | Commercial Services |
| The United States Army Medical Service Corps |
